Case Report: Concurrent de novo pathogenic variants in the LMNA gene as a cause of sporadic partial lipodystrophy

Front Genet. 2024 Nov 28:15:1468878. doi: 10.3389/fgene.2024.1468878. eCollection 2024.

Abstract

Introduction: Inherited lipodystrophies are a group of rare diseases defined by severe reduction in adipose tissue mass and classified as generalized or partial. We report a non-familial (sporadic) case of partial lipodystrophy caused by a novel genetic mechanism involving closely linked de novo pathogenic variants in the LMNA gene.

Methods: A female adult with partial lipodystrophy and her parents were evaluated for gene variants across the exome under different mendelian inheritance models (autosomal dominant, recessive, compound heterozygous, and X-linked) to find pathogenic variants. Body composition was assessed via dual-energy X-ray absorptiometry (DXA).

Results: The patient showed absence of adipose tissue in the limbs; preservation of adiposity in the face, neck, and trunk; muscular hypertrophy, hypertriglyceridemia and insulin resistance. DXA revealed a fat mass of 15.4%, with android-to-gynoid ratio, trunk/limb, and trunk/leg ratios exceeding the published upper limits of 90% reference intervals. Two heterozygous missense de novo pathogenic variants in cis within the LMNA gene were found in the proband: p.Y481H and p.K486N (NP_733821.1). These variants have functional effects and were reported in inherited Emery-Dreifuss muscular dystrophy 2 (p.Y481H) and familial partial lipodystrophy type 2 (p.K486N). Molecular modeling analyses provided additional insights into the protein instability conferred by these variants in the lamin A/C Ig-like domain.

Conclusion: In a case of sporadic partial lipodystrophy, we describe two concurrent de novo pathogenic variants within the same gene (LMNA) as a novel pathogenic mechanism. This finding expands the genetic and phenotypic spectrum of partial lipodystrophy and laminopathy syndromes.

Keywords: LMNA; de novo; exome; lipodystrophy; pathogenic mutation.

Publication types

  • Case Reports

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research is supported by FONDECYT 1221146, Anillo ACT210039 and Fondequip EQM230130 to VC. JLS acknowledges the support from FONDECYT 1150416. CFL acknowledges support from Centro Basal Ciencia and Vida, FB210008/ANID. Powered@NLHPC: This research was partially supported by the supercomputing infrastructure of the NLHPC (CCSS210001). Genotyping of Chilean ECO participants for allele frequencies was performed at the Spanish National Cancer Research Centre in the Human Genotyping lab, a member of CeGen, PRB3, and supported by grant PT17/0019, of the PE I + D + i 2013–2016, funded by ISCIII and ERDF.